More companies were added to a U.S. Food and Drug Administration recall of blood pressure and heart medicine containing a possible carcinogen, according to an update on Aug. 8.
Valsartan, according to the FDA, is used as a component in drugs that is to treat high blood pressure as well as congestive heart failure. The FDA initiated its first recall July 13 after tests showed the drugs could contain N-Nitrosodimethylamine (NDMA).
